Author Index

Search or browse for an author across our entire electronic archive

Search results for: A
Results 1 - 10 of 1010 shown below

  • A'Hern, R

    S Shah, J Hardy, E Rees, J Ling, B Gwilliam, C Davis, K Broadley and R A'Hern

    Is there a dose response relationship for clodronate in the treatment of tumour induced hypercalcaemia?

    doi:10.1038/sj.bjc.6600249

    Abstract | Full article | PDF

  • A'Hern, R P

    S L Morris, S H Low, R P A'Hern, T G Eisen, M E Gore, C M Nutting and K J Harrington

    A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma

    advance online publication, 2004-08-10 00:00:00.000;

    doi:10.1038/sj.bjc.6602018

    Abstract | Full article | PDF

  • Açil, Y

    I N G Springer, H Terheyden, A Dunsche, N Czech, M A A Suhr, M Tiemann, J Hedderich and Y Açil

    Collagen crosslink excretion and staging of oral cancer

    doi:10.1038/sj.bjc.6600873

    Abstract | Full article | PDF

  • I N G Springer, H Terheyden, M A A Suhr, P Warnke, A Dunsche, M Tiemann and Y Açil

    Follow-up of collagen crosslink excretion in patients with oral squamous cell carcinoma and analysis of tissue samples

    doi:10.1038/sj.bjc.6601325

    Abstract | Full article | PDF

  • A'Hern, R

    S Jefferies, R Eeles, D Goldgar, R A'Hern, M Gore, D Archer, K Bishop, A Murkin, E Solomon, S Hodgsun, M O'Connell, J Hibbert, D Easton and W Foulkes

    The role of genetic factors in predisposition to squamous cell cancer of the head and neck

    doi:10.1038/sj.bjc.6690138

    Abstract | Full article | PDF

  • P Stone, J Hardy, K Broadley, A Kurowska and R A'Hern

    Fatigue in advanced cancer: a prospective controlled cross-sectional study

    doi:10.1038/sj.bjc.6690236

    Abstract | Full article | PDF

  • M Partridge, G Emilion, S Pateromichelakis, R A'Hern, G Lee, E Phillips and J Langdon

    The prognostic significance of allelic imbalance at key chromosomal loci in oral cancer

    doi:10.1038/sj.bjc.6690290

    Abstract | Full article | PDF

  • N Rahman, J G Stone, G Coleman, B Gusterson, S Seal, A Marossy, S R Lakhani, A Ward, A Nash, A McKinna, R A'Hern, M R Stratton and R S Houlston

    Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene

    doi:10.1054/bjoc.1999.0965

    Abstract | Full article | PDF

  • S Jefferies, S M Edwards, R A Hamoudi, R A'Hern, W Foulkes, D Goldgar and R Eeles

    No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours

    doi:10.1054/bjoc.2001.2068

    Abstract | Full article | PDF

  • A'Hern, R

    J S Waters, C Moss, L Pyle, M James, S Hackett, R A'Hern, M Gore and T Eisen

    Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma

    advance online publication, 2004-10-26 00:00:00.000;

    doi:10.1038/sj.bjc.6602209

    Abstract | Full article | PDF

  • A'hern, R P

    A M Kirby, R P A'hern, C D'ambrosio, M Tanay, K N Syrigos, S J Rogers, C Box, S A Eccles, C M Nutting and K J Harrington

    Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer

    advance online publication, 2006-02-21 00:00:00.000;

    doi:10.1038/sj.bjc.6602999

    Abstract | Full article | PDF

  • Aaboe, M

    M Aaboe, N Marcussen, K M-E Jensen, T Thykjaer, L Dyrskjøt and T F Ørntoft

    Gene expression profiling of noninvasive primary urothelial tumours using microarrays

    advance online publication, 2005-11-01 00:00:00.000;

    doi:10.1038/sj.bjc.6602813

    Abstract | Full article | PDF

  • J B Andersen, M Aaboe, E C Borden, O G Goloubeva, B A Hassel and T F Ørntoft

    Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer

    advance online publication, 2006-04-25 00:00:00.000;

    doi:10.1038/sj.bjc.6603099

    Abstract | Full article | PDF

  • Aalame, N

    M Pruschy, H Resch, Y-Q Shi, N Aalame, C Glanzmann and S Bodis

    Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells

    doi:10.1038/sj.bjc.6690411

    Abstract | Full article | PDF

  • Aalders, J G

    L S Hofstra, A M E Bos, E G E de Vries, A G J van der Zee, J H Beijnen, H Rosing, N H Mulder, J G Aalders and P H B Willemse

    A phase I and pharmacokinetic study of intraperitoneal topotecan

    doi:10.1054/bjoc.2001.2161

    Abstract | Full article | PDF

  • Aalders, M

    A Kuin, M Aalders, M Lamfers, M Essers and L A Smets

    Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG)

    doi:10.1038/sj.bjc.6690127

    Abstract | Full article | PDF